Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/23/2008US20080260785 Mixture of paroxetine with acid resistant polymer; sustained release; bioavailability
10/23/2008US20080260774 Activation cytokine response in immune system including lymphocyte and antigen; anticancer agents; infection diseases; autoimmune disease; vaccine
10/23/2008US20080260771 Mixture with plant extracts; side effect reduction
10/23/2008US20080260769 Protein comprising antigenic, oligomerization, transmembrane and adhesin domains; improving membrane surface expression of heterologous protein
10/23/2008US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins
10/23/2008US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia
10/23/2008US20080260754 Prevent transplant rejection; autoimmune diseases
10/23/2008US20080260753 Transgenic animal model expressing NOD mutant for use in identifying modulator for treatment of inflammatory bowel disease
10/23/2008US20080260751 Using activator of toll like receptor-4 protein as therapeutic in treatment and prevention of arthritic, inflammatory, kidney, skin bone, respiratory, brain, cell proliferative and liver disorders
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260749 Novel Tetrahydropyridothiophenes
10/23/2008US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260744 Using neuronal membrane protein receptor as screening tool in identifying modulators for treatment of brain disorders
10/23/2008US20080260743 Means and Methods for Detecting Methylated Dna
10/23/2008US20080260742 Preventives/Remedies for Cancer
10/23/2008US20080260741 Preventive and/or Therapeutic Agent for Cancer
10/23/2008US20080260739 Use of Anti-Mortalin 2 Antibody and Functional Nucleic Acid for Cancer Therapies
10/23/2008US20080260735 Glycoprotein-340 for use in targeted destruction of cancer tissues; immunotherapy
10/23/2008US20080260729 Using RNA interference and/or endothelial growth factor specific immunoglobulins to target, treat and prevent cell proliferative disorsders
10/23/2008US20080260725 Tag and target delivery system
10/23/2008US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes
10/23/2008US20080260720 Systems and Methods for Inhibiting Metastasis
10/23/2008US20080260719 EDG: Modulators of lymphocyte activation and migration
10/23/2008US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception
10/23/2008US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage
10/23/2008US20080260713 Neukinase, A Downstream protein of neuregulin
10/23/2008US20080260712 Apparatus which enhances stability of invertebrate discs by reducing bending hysteresis of scoliotic spines; improving resistance of collagenous tissue to mechanical degradation
10/23/2008US20080260708 Nutrient broth for enhancing the body's innate ability to self-heal and self-regulate
10/23/2008US20080260706 Transient Transfection with RNA
10/23/2008US20080260702 Using vector comprising nucleotide sequences coding neublastin as therapeutic treatment for vision defects
10/23/2008US20080260696 Method for decreasing inflammation and oxidative stress in mammals
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008US20080260682 Polyethylene glycol colonic purgative composition
10/23/2008US20080260681 Using poloxamer; therapy for cardiovascular disorders, muscular dystrophy, apoptosis and antiischemic agents
10/23/2008US20080260680 Method of Attenuating Reactions to Skin Irritants
10/23/2008US20080260679 Methods and compositions for treatment of ion imbalances
10/23/2008US20080260678 Molecular band-aid
10/23/2008US20080260677 Transdermal Topical Composition and Its Uses
10/23/2008US20080260675 Depolymerized Scleroglucan for Regulating and Improving the Moisture Content of the Skin
10/23/2008US20080260669 Aromachemicals
10/23/2008US20080260659 Personal care product containing preservative and benzaldehyde enhancer
10/23/2008US20080260656 Ungual/periungual compositions comprising morpholine compounds and water-soluble film-forming agents
10/23/2008US20080260653 Topical chelation compounds; applying to skins of humans, animals
10/23/2008US20080260644 Adjust concentration of chloride channel moderators within brain
10/23/2008US20080260643 Use of pde7 inhibitors for the treatment of movement disorders
10/23/2008US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
10/23/2008DE10341317B4 Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid The transdermal therapeutic system (TTS) except for the administration of pergolide ergoline compounds
10/23/2008DE102007045242A1 Benzaldehyde in kosmetischen oder dermatologischen Zubereitungen Benzaldehydes in cosmetic or dermatological preparations
10/23/2008DE102007045241A1 Cosmetic preparation, useful as an agent that is effective against e.g. gram negative and gram positive bacteria, yeast and/or fungus, comprises piroctone olamine and stabilizing agent e.g. benzaldehyde and/or alkane-diol
10/23/2008DE102007018662A1 Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie Oxazolidinones for the treatment and prophylaxis of pulmonary hypertension
10/23/2008DE102007018151A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/23/2008DE102007018150A1 Treating pain, using dual action compound or combination of compounds with affinity for both mu-opioid and vanilloid VR1-receptors, also effective e.g. against coughs or asthma
10/23/2008DE102007018149A1 Substituted compound for producing pharmaceuticals for treating or prophylaxis of pain, nerve injuries, respiratory disorder, has general formulae
10/23/2008DE102007016046A1 Verfahren zur Herstellung von Epothilonderivaten durch selektive katalytische Epoxidierung Process for the preparation of epothilone derivatives by selective catalytic epoxidation
10/23/2008CA2817754A1 Oligo-guluronate and galacturonate compositions
10/23/2008CA2783587A1 Method for manufacturing neuraminic acid derivatives
10/23/2008CA2721133A1 Low-dose doxepin formulations and methods of making and using the same
10/23/2008CA2703011A1 Oxazolidinone derivatives and methods of use
10/23/2008CA2688725A1 Methods for treating spinal muscular atrophy using tetracycline compounds
10/23/2008CA2684363A1 Use of dimiracetam in the treatment of chronic pain
10/23/2008CA2684219A1 Oral cephalotaxine dosage forms
10/23/2008CA2684213A1 Ischemia/reperfusion protection compositions and methods of using
10/23/2008CA2684211A1 Hydroquinone ansamycin formulations
10/23/2008CA2684059A1 Use of a ppary agonist, alone or in combination, for the treatment or prophylaxis of addictions
10/23/2008CA2684056A1 Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer
10/23/2008CA2684042A1 Use of substrates as pharmacological chaperones
10/23/2008CA2684008A1 Diphenyl-dihydro-imidazopyridinones
10/23/2008CA2683973A1 Sparc and methods of use thereof
10/23/2008CA2683963A1 Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
10/23/2008CA2683919A1 Benzofuran- carboxamide derivatives as antiviral agents
10/23/2008CA2683915A1 Pyrimidinedione derivatives and methods of use thereof
10/23/2008CA2683914A1 Oligo-guluronate and galacturonate compositions
10/23/2008CA2683890A1 Methods and compositions for contributing to the treatment of cancers
10/23/2008CA2683852A1 Novel compounds
10/23/2008CA2683820A1 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
10/23/2008CA2683797A1 Means and methods for counteracting protein aggregation
10/23/2008CA2683793A1 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
10/23/2008CA2683785A1 Aminopyrimidines useful as kinase inhibitors
10/23/2008CA2683784A1 Pyrido[2,3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
10/23/2008CA2683767A1 Selective androgen receptor modulators for treating diabetes
10/23/2008CA2683746A1 Naturally-derived emulsifier system
10/23/2008CA2683719A1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/23/2008CA2683713A1 Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
10/23/2008CA2683695A1 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
10/23/2008CA2683637A1 Methods for treating neoplasia with combination of chemotherapeutic agents and radiation
10/23/2008CA2683624A1 Pharmaceutical compounds
10/23/2008CA2683622A1 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
10/23/2008CA2683619A1 Pharmaceutical compounds
10/23/2008CA2683607A1 Use of cyclohexanehexol derivatives in the treatment of ocular diseases
10/23/2008CA2683603A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/23/2008CA2683586A1 Substituted furo[2,3-beta]pyridine derivatives as cannabinoid 1-receptor modulators
10/23/2008CA2683581A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
10/23/2008CA2683580A1 Treatment of amyotrophic lateral sclerosis
10/23/2008CA2683559A1 Methods for treating cancer resistant to erbb therapeutics
10/23/2008CA2683548A1 Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
10/23/2008CA2683546A1 Use of cyclohexanehexol derivatives in the treatment of .alpha.-synucleinopathies
10/23/2008CA2683522A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
10/23/2008CA2683469A1 Genetic suppression and replacement
1 ... 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 ... 7860